N
Fame Shock News

which of the following is required at a prestudy site visit?

Author

Rachel Fowler

Updated on July 30, 2026

Pre-study visits (site selection visits or site qualification visits (SQVs)) are conducted to determine if the investigator and clinical site have the capability to conduct the study. During this visit, both an investigator and a study coordinator must be available.

At which study visits can the site expect the sponsor to review subjects signed informed consent forms?

At which study visits can the site expect the sponsor to review subjects’ signed informed consent forms? Periodic and termination site visits. The subject informed consent forms are reviewed at the periodic site visits and the termination site visit.

What is a monitoring visit in clinical trials?

Monitoring is defined as the act of overseeing the progress of a clinical trial, and of ensuring that it is conducted, recorded, and reported in accordance with the protocol, SOPs, The Principles of GCP, and the Medicines for Human Use (Clinical Trails) Regulations – where applicable.

What is a site qualification visit?

Site Qualification Visit (SQV): A meeting with a representative from a sponsor representative to ensure the institution is fully capable and equipped to run a specific clinical trial. This visit may also be referred to as Site Selection Visit (SSV) or Pre-Study Qualification Visit (PSQV).

What happens during site initiation visit?

The Site Initiation Visit (SIV) prepares the research site to conduct the research study. This meeting generally takes place after the investigational site has received IRB approval and a Clinical Trial Agreement (CTA) has been fully executed. In addition, the SIV should occur prior to the first subject enrollment.

What is a monitoring checklist?

The Monitoring Checklist is used at site visits to assess the performance of the grantees and during the competitive process to determine a past performance adjustment to the scores of the applicants.

What is site monitoring plan?

The monitoring plan is the document that details the monitoring policies and procedures, and the proposed frequency of on-site monitoring visits across the trial sites, for a particular trial. The following details should be included in the monitoring plan: Monitoring strategy and its rationale.

What do you review during a clinical site monitoring visit and why?

The main purpose of the interim monitoring visits is to review and discuss the study conduct, to confirm that subjects’ safety and welfare is protected at your site, to review storage conditions, allocation and accountability of the investigational drug(s), to perform SDV and to ensure that trial data produced by the

What does the CRA review at site to support all CRF entries?

The study monitor (CRA) or central data coordinator will often review the CRFs for legibility, completeness, and consistency. Any data that is missing or errors identified by the study coordinator or monitor will need to be resolved.

When on site monitoring activities are conducted?

Traditionally, the pharmaceutical industry has assessed site performance and addressed site risk using On-site monitoring. This approach is carried out by an individual who visits the trial site at regular intervals, e.g., every four to six weeks to ensure everything is running smoothly.

Which of the following is an acceptable criterion for determining that a study of an approved?

Which of the following is an acceptable criterion for determining that a study of an approved drug does not require an IND? The study is not intended to be reported to FDA to support a new indication or support a labeling change.

What are essential documents in a clinical trial?

The essential documents for clinical trials are the following: Investigator’s Brochure. Clinical Study Protocol. Subject Information and Informed Consent Form.

What is clinical trial protocol?

The protocol is a document that describes how a clinical trial will be conducted (the objective(s), design, methodology, statistical considerations and organization of a clinical trial,) and ensures the safety of the trial subjects and integrity of the data collected.

What is a site evaluation visit?

A Site Evaluation Visit (SEV) is conducted by the Sponsor or CRO to evaluate a Site’s and Investigator’s resources and capabilities to conduct a study. This type of visit is also referred to as an SSV (Site Selection Visit) or SQV (Site Qualification Visit).